{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:31:15Z","timestamp":1786404675738,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SRM Institute of Science & Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55753-w","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:34:03Z","timestamp":1780155243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a biomarker-enhanced arterial age model for young-to-middle-aged adults with type 2 diabetes"],"prefix":"10.1038","volume":"16","author":[{"given":"Rooban","family":"Sivakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. A.","family":"Arul Senghor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. M.","family":"Vinodhini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"55753_CR1","doi-asserted-by":"publisher","unstructured":"Irini Genitsaridi, P. et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. The Lancet Diabetes & Endocrinology. Published online December 1, 2025. https:\/\/doi.org\/10.1016\/s2213-8587(25)00299-2","DOI":"10.1016\/s2213-8587(25)00299-2"},{"key":"55753_CR2","doi-asserted-by":"publisher","first-page":"e09","DOI":"10.15420\/ecr.2024.29","volume":"20","author":"M Berger","year":"2025","unstructured":"Berger, M., Marx, N. & Marx-Sch\u00fctt, K. Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: What Does the Cardiologist Need to Know? Eur. Cardiol. 20, e09. https:\/\/doi.org\/10.15420\/ecr.2024.29 (2025). Published 2025 Apr 15.","journal-title":"Eur. Cardiol."},{"issue":"9","key":"55753_CR3","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","volume":"145","author":"JJ Joseph","year":"2022","unstructured":"Joseph, J. J. et al. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association. Circulation 145 (9), e722\u2013e759. https:\/\/doi.org\/10.1161\/CIR.0000000000001040 (2022).","journal-title":"Circulation"},{"issue":"1","key":"55753_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal. Transduct. Target. Therapy. 8 (1), 1\u201329. https:\/\/doi.org\/10.1038\/s41392-023-01400-z (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"55753_CR5","doi-asserted-by":"publisher","unstructured":"Yang, D. R., Wang, M. Y., Zhang, C. L. & Wang, Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front. Endocrinol. 15 https:\/\/doi.org\/10.3389\/fendo.2024.1359255 (2024).","DOI":"10.3389\/fendo.2024.1359255"},{"key":"55753_CR6","doi-asserted-by":"publisher","unstructured":"Herzog, M. J. et al. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. Signal. Transduct. Target. Therapy. 10 (1). https:\/\/doi.org\/10.1038\/s41392-025-02346-0 (2025).","DOI":"10.1038\/s41392-025-02346-0"},{"issue":"10","key":"55753_CR7","doi-asserted-by":"publisher","first-page":"109118","DOI":"10.1016\/j.jdiacomp.2025.109118","volume":"39","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z., Yang, R., Wu, W. & Wang, Z. Association of aortic pulse wave velocity with cardiovascular outcomes and all-cause mortality in diabetes: A systematic review and meta-analysis. J. Diabetes Complications. 39 (10), 109118. https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109118 (2025).","journal-title":"J. Diabetes Complications"},{"key":"55753_CR8","doi-asserted-by":"publisher","unstructured":"Laura, Romero-Orjuela, S. P. & Rabeya, F. J. Valeria del Castillo, Echeverri D. Age and vascular aging: an unexplored frontier. Front. Cardiovasc. Med. 10 https:\/\/doi.org\/10.3389\/fcvm.2023.1278795 (2023).","DOI":"10.3389\/fcvm.2023.1278795"},{"issue":"12","key":"55753_CR9","doi-asserted-by":"publisher","first-page":"121001","DOI":"10.1088\/1361-6579\/ad548e","volume":"45","author":"S Zanelli","year":"2024","unstructured":"Zanelli, S. et al. Developing technologies to assess vascular ageing: a roadmap from VascAgeNet. Physiol. Meas. 45 (12), 121001. https:\/\/doi.org\/10.1088\/1361-6579\/ad548e (2024). Published 2024 Dec 30.","journal-title":"Physiol. Meas."},{"issue":"1","key":"55753_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.123.21618","volume":"81","author":"B Spronck","year":"2024","unstructured":"Spronck, B. et al. 2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices. Hypertension 81 (1), 183\u2013192. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21618 (2024).","journal-title":"Hypertension"},{"issue":"4","key":"55753_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3904\/kjim.2024.015","volume":"39","author":"HJ Kim","year":"2024","unstructured":"Kim, H. J., Kim, B. S., Kim, D. W. & Shin, J. H. Estimated pulse wave velocity as a forefront indicator of developing metabolic syndrome in Korean adults. Korean J. Intern. Med. 39 (4), 612\u2013624. https:\/\/doi.org\/10.3904\/kjim.2024.015 (2024).","journal-title":"Korean J. Intern. Med."},{"issue":"1","key":"55753_CR12","doi-asserted-by":"publisher","first-page":"e0280896","DOI":"10.1371\/journal.pone.0280896","volume":"18","author":"KS Heffernan","year":"2023","unstructured":"Heffernan, K. S., Stoner, L., London, A. S., Augustine, J. A. & Lefferts, W. K. Estimated pulse wave velocity as a measure of vascular aging. PLoS One. 18 (1), e0280896. https:\/\/doi.org\/10.1371\/journal.pone.0280896 (2023). Published 2023 Jan 26.","journal-title":"PLoS One"},{"key":"55753_CR13","doi-asserted-by":"publisher","unstructured":"Li, J. et al. Association of estimated pulse wave velocity with cardiovascular disease outcomes and all-cause death-a systematic review and meta-analysis. Front Cardiovasc Med. ;12:1641697. Published 2025 Sep 16. (2025). https:\/\/doi.org\/10.3389\/fcvm.2025.1641697","DOI":"10.3389\/fcvm.2025.1641697"},{"key":"55753_CR14","doi-asserted-by":"publisher","unstructured":"Liu, C. et al. Association of arterial stiffness with all-cause and cause-specific mortality in the diabetic population: A national cohort study. Front. Endocrinol. 14. https:\/\/doi.org\/10.3389\/fendo.2023.1145914 (2023).","DOI":"10.3389\/fendo.2023.1145914"},{"key":"55753_CR15","doi-asserted-by":"publisher","unstructured":"Ceriello, A. et al. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target. Cardiovasc. Diabetol. 21 (1). https:\/\/doi.org\/10.1186\/s12933-022-01445-4 (2022).","DOI":"10.1186\/s12933-022-01445-4"},{"issue":"1","key":"55753_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12933-023-01884-7","volume":"22","author":"Q Fang","year":"2023","unstructured":"Fang, Q. et al. Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes. Cardiovasc. Diabetol. 22 (1), 167. https:\/\/doi.org\/10.1186\/s12933-023-01884-7 (2023). Published 2023 Jul 6.","journal-title":"Cardiovasc. Diabetol."},{"key":"55753_CR17","doi-asserted-by":"publisher","unstructured":"Li, K., Cao, B., Dong, H., Yang, L. & Zhao, D. Trajectories of glycated hemoglobin of T2DM and progress of arterial stiffness: a prospective study. Diabetol. Metab. Syndr. 15 (1). https:\/\/doi.org\/10.1186\/s13098-023-01108-8 (2023).","DOI":"10.1186\/s13098-023-01108-8"},{"issue":"4","key":"55753_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s13167-023-00347-z","volume":"14","author":"C Cui","year":"2023","unstructured":"Cui, C. et al. Diabetes, glycemic control and arterial stiffness: a real-world cohort study in the context of predictive, preventive, and personalized medicine. EPMA J. 14 (4), 663\u2013672. https:\/\/doi.org\/10.1007\/s13167-023-00347-z (2023). Published 2023 Nov 24.","journal-title":"EPMA J."},{"issue":"5","key":"55753_CR19","doi-asserted-by":"publisher","first-page":"H879","DOI":"10.1152\/ajpheart.00385.2022","volume":"323","author":"TJ Jurrissen","year":"2022","unstructured":"Jurrissen, T. J. et al. Role of adropin in arterial stiffening associated with obesity and type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 323 (5), H879\u2013H891. https:\/\/doi.org\/10.1152\/ajpheart.00385.2022 (2022).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"55753_CR20","doi-asserted-by":"publisher","unstructured":"Wei, W. et al. The association between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus: a cross-sectional study. Diabetol. Metab. Syndr. 14 (1). https:\/\/doi.org\/10.1186\/s13098-022-00796-y (2022).","DOI":"10.1186\/s13098-022-00796-y"},{"key":"55753_CR21","doi-asserted-by":"publisher","unstructured":"Tabak, O. et al. Serum adropin and miR-21 expression as predictors of endothelial dysfunction in type 2 diabetes mellitus and vascular complications. Sci. Rep. 15 (1). https:\/\/doi.org\/10.1038\/s41598-025-20873-2 (2025).","DOI":"10.1038\/s41598-025-20873-2"},{"key":"55753_CR22","doi-asserted-by":"publisher","unstructured":"Dogan, Z. et al. The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes. Sci. Rep. 15 (1). https:\/\/doi.org\/10.1038\/s41598-025-89220-9 (2025).","DOI":"10.1038\/s41598-025-89220-9"},{"key":"55753_CR23","doi-asserted-by":"publisher","first-page":"110040","DOI":"10.1016\/j.diabres.2022.110040","volume":"191","author":"L Xu","year":"2022","unstructured":"Xu, L., Yan, X., Tang, Z. & Feng, B. Association between circulating oxidized OxLDL\/LDL-C ratio and the severity of coronary atherosclerosis, along with other emerging biomarkers of cardiovascular disease in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 191, 110040. https:\/\/doi.org\/10.1016\/j.diabres.2022.110040 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"9","key":"55753_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.31083\/j.rcm2509339","volume":"25","author":"X Liang","year":"2024","unstructured":"Liang, X. et al. Aortic Stiffness Measured by Carotid Femoral-Pulse Wave Velocity at Different Stages of Normal Glucose, Prediabetes, and Diabetes Mellitus: A Systematic Review and Meta-Analysis. Rev. Cardiovasc. Med. 25 (9), 339. https:\/\/doi.org\/10.31083\/j.rcm2509339 (2024). Published 2024 Sep 23.","journal-title":"Rev. Cardiovasc. Med."},{"key":"55753_CR25","doi-asserted-by":"publisher","unstructured":"Li, B. et al. Adropin Improves Radiation-Induced Myocardial Injury via VEGFR2\/PI3K\/Akt Pathway. ;2022:1\u201311. (2022). https:\/\/doi.org\/10.1155\/2022\/8230214","DOI":"10.1155\/2022\/8230214"},{"key":"55753_CR26","doi-asserted-by":"publisher","unstructured":"Wu, L., Fang, J., Yuan, X., Xiong, C. & Chen, L. Adropin reduces hypoxia\/reoxygenation\u2013induced myocardial injury via the reperfusion injury salvage kinase pathway. Experimental Therapeutic Med. Published online August. 26 https:\/\/doi.org\/10.3892\/etm.2019.7937 (2019).","DOI":"10.3892\/etm.2019.7937"},{"key":"55753_CR27","doi-asserted-by":"publisher","unstructured":"Li, B. et al. Adropin as a therapeutic candidate for HFpEF: evidence of oxidative stress mitigation via Nrf2\/HO-1 signaling. Lipids Health Dis. 24 (1). https:\/\/doi.org\/10.1186\/s12944-025-02703-6 (2025).","DOI":"10.1186\/s12944-025-02703-6"},{"key":"55753_CR28","doi-asserted-by":"publisher","unstructured":"Wendt, T. S., Ansar, S. & Gonzales, R. J. OxLDL\/LOX-1 mediated sex, age, stiffness, and endothelial dependent alterations in mouse thoracic aortic vascular reactivity. Front Physiol. ;15:1471272. Published 2024 Nov 5. (2024). https:\/\/doi.org\/10.3389\/fphys.2024.1471272","DOI":"10.3389\/fphys.2024.1471272"},{"key":"55753_CR29","doi-asserted-by":"publisher","unstructured":"Jiang, H. et al. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. Front Cardiovasc Med. ;9:925923. Published 2022 Jun 1. (2022). https:\/\/doi.org\/10.3389\/fcvm.2022.925923","DOI":"10.3389\/fcvm.2022.925923"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55753-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:24:10Z","timestamp":1786404250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55753-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55753"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55753-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the SRM institutional Ethics Committee, under approval number ECR\/8856\/INST\/TN\/2013\/RR-19. Written informed consent was obtained from all participants before their inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any person\u2019s data in any form (including individual details, images, or videos).","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the author(s) used Quillbot to improve writing language. After using Quillbot, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":3,"name":"Ethics","label":"Declarations","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24803"}}